PD-010 - A multi-cohort phase 1 study of ramucirumab plus durvalumab: Preliminary safety and clinical activity in patients with locally advanced and unresectable or metastatic gastric or gastroesophageal junction adenocarcinoma
- Resource Type
- Abstract
- Source
- In
Annals of Oncology June 2017 28 Supplement 3:iii5-iii5 - Subject
- Language
- ISSN
- 0923-7534